SCHEDULE 13G

Company

Anixa Biosciences Inc

Filed

January 3, 2017

Accession Number

0001513162-17-000004

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →